[1]
Welsh N. 2022. Are off-target effects of imatinib the key to improving beta-cell function in diabetes?. Upsala Journal of Medical Sciences. 127, 1 (Sep. 2022). DOI:https://doi.org/10.48101/ujms.v127.8841.